Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kramer

Showing results (181-190 of 240) with videos related to

Pageof 24
Sort By:
NIH Consensus and State-Of-The-Science Statements|November 3, 2010
NIH consensus development conference: Inhaled nitric oxide therapy for premature infantsF Sessions Cole, Claudia Alleyne, John D E Barks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 studyMarkus Schaich, Christoph Röllig, Silke Soucek, et al.
Blood|January 26, 2017
Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemiaTilmann Bochtler, Martin Granzow, Friedrich Stölzel, et al.
Lancet (London, England)|August 11, 2012
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised studyHannes Wandt, Kerstin Schaefer-Eckart, Knut Wendelin, et al.
The Lancet. Haematology|April 10, 2018
Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trialMartin Wermke, Julia Eckoldt, Katharina S Götze, et al.
Journal of Global Health|December 1, 2012
Setting research priorities to reduce global mortality from preterm birth and low birth weight by 2015Rajiv Bahl, Jose Martines, Nita Bhandari, et al.
Pediatrics|January 12, 2011
NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infantsF Sessions Cole, Claudia Alleyne, John D E Barks, et al.
Hemasphere|October 19, 2022
Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid MalignanciesMartin Kirschner, Benjamin Rolles, Martina Crysandt, et al.
Frontiers in Oncology|April 7, 2022
Point Mutations in the <i>FLT3</i>-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant <i>KMT2A</i>-PTDSebastian Stasik, Michael Kramer, Sven Zukunft, et al.
Blood Advances|September 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AMLJulia M Unglaub, Richard F Schlenk, Jan Moritz Middeke, et al.
Pageof 24

Showing results (181-190 of 240) with videos related to

Sort By:
Pageof 24
NIH Consensus and State-Of-The-Science Statements|November 3, 2010
NIH consensus development conference: Inhaled nitric oxide therapy for premature infantsF Sessions Cole, Claudia Alleyne, John D E Barks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 studyMarkus Schaich, Christoph Röllig, Silke Soucek, et al.
Blood|January 26, 2017
Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemiaTilmann Bochtler, Martin Granzow, Friedrich Stölzel, et al.
Lancet (London, England)|August 11, 2012
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised studyHannes Wandt, Kerstin Schaefer-Eckart, Knut Wendelin, et al.
The Lancet. Haematology|April 10, 2018
Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trialMartin Wermke, Julia Eckoldt, Katharina S Götze, et al.
Journal of Global Health|December 1, 2012
Setting research priorities to reduce global mortality from preterm birth and low birth weight by 2015Rajiv Bahl, Jose Martines, Nita Bhandari, et al.
Pediatrics|January 12, 2011
NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infantsF Sessions Cole, Claudia Alleyne, John D E Barks, et al.
Hemasphere|October 19, 2022
Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid MalignanciesMartin Kirschner, Benjamin Rolles, Martina Crysandt, et al.
Frontiers in Oncology|April 7, 2022
Point Mutations in the <i>FLT3</i>-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant <i>KMT2A</i>-PTDSebastian Stasik, Michael Kramer, Sven Zukunft, et al.
Blood Advances|September 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AMLJulia M Unglaub, Richard F Schlenk, Jan Moritz Middeke, et al.
Pageof 24